15:51 Dec 27
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:51 Dec 27
Quality
75/100
High Financial Strength
Valuation
12/100
Expensive Valuation
Technical
62/100
Technically Moderately Bullish
Strength
12
Weakness
1
Opportunity
1
Threats
1
0.40 %
Dividend Yield
22.65K
Market Cap (Cr)
57.27
RSI
44.08 %
Promoter Holding
30.29 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
